BioSig Technologies Appoints New CFO, Adjusts Officer Compensation
Ticker: STEX · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $15,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, compensation, board-changes
TL;DR
BioSig names Kevin O'Boyle CFO, base salary $350k. Board changes too.
AI Summary
BioSig Technologies, Inc. announced on June 5, 2024, the appointment of Kevin T. O'Boyle as Chief Financial Officer. O'Boyle, who previously served as interim CFO, will receive an annual base salary of $350,000 and is eligible for a discretionary bonus. The company also reported on the election of new directors and changes in officer compensation.
Why It Matters
The appointment of a permanent CFO and adjustments to compensation can signal a new phase of financial strategy and stability for the company.
Risk Assessment
Risk Level: medium — Changes in key executive positions and compensation can introduce uncertainty regarding future financial strategy and operational execution.
Key Numbers
- $350,000 — CFO Annual Base Salary (Kevin T. O'Boyle's starting compensation as permanent CFO.)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- Kevin T. O'Boyle (person) — Appointed Chief Financial Officer
- $350,000 (dollar_amount) — Annual base salary for CFO
- June 5, 2024 (date) — Date of earliest event reported
FAQ
What is the effective date of Kevin T. O'Boyle's appointment as CFO?
The filing indicates June 5, 2024, as the date of the earliest event reported, which includes the appointment of officers.
What is Kevin T. O'Boyle's annual base salary?
Kevin T. O'Boyle's annual base salary is $350,000.
Are there any other changes to officer compensation mentioned?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item of information, suggesting other compensation adjustments may be detailed.
Who were the newly elected directors?
The filing lists 'Election of Directors' as an item of information, but the names of the newly elected directors are not explicitly stated in the provided text.
What is BioSig Technologies, Inc.'s state of incorporation?
BioSig Technologies, Inc. is incorporated in Delaware.
Filing Stats: 788 words · 3 min read · ~3 pages · Grade level 10.6 · Accepted 2024-06-10 09:45:12
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The NASDAQ Capital M
- $15,000 — des for compensation at a fixed rate of $15,000 per month and reimbursement by the Comp
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 13KB
- 0001493152-24-023293.txt ( ) — 231KB
- bsgm-20240605.xsd (EX-101.SCH) — 3KB
- bsgm-20240605_lab.xml (EX-101.LAB) — 33KB
- bsgm-20240605_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: June 10, 2024 By: /s/ Anthony Amato Name: Anthony Amato Title: Chief Executive Officer